AU2001262149A1 - 2-(indanylamino)pyrimidone and 2-(tetrahydronaphthalenylamino)pyrimidone derivatives - Google Patents

2-(indanylamino)pyrimidone and 2-(tetrahydronaphthalenylamino)pyrimidone derivatives

Info

Publication number
AU2001262149A1
AU2001262149A1 AU2001262149A AU6214901A AU2001262149A1 AU 2001262149 A1 AU2001262149 A1 AU 2001262149A1 AU 2001262149 A AU2001262149 A AU 2001262149A AU 6214901 A AU6214901 A AU 6214901A AU 2001262149 A1 AU2001262149 A1 AU 2001262149A1
Authority
AU
Australia
Prior art keywords
pyrimidone
tetrahydronaphthalenylamino
indanylamino
derivatives
pyrimidone derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262149A
Inventor
Antonio Almario Garcia
Jonathan Reid Frost
Adrien Tak Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Mitsubishi Tokyo Pharmaceuticals Inc
Original Assignee
Sanofi Synthelabo SA
Mitsubishi Tokyo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA, Mitsubishi Tokyo Pharmaceuticals Inc filed Critical Sanofi Synthelabo SA
Publication of AU2001262149A1 publication Critical patent/AU2001262149A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
AU2001262149A 2000-03-23 2001-03-22 2-(indanylamino)pyrimidone and 2-(tetrahydronaphthalenylamino)pyrimidone derivatives Abandoned AU2001262149A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00400808 2000-03-23
EP00400808A EP1136486A1 (en) 2000-03-23 2000-03-23 2-[Indanylamino]pyrimidone and 2-[tetrahydronaphthalenylamino]pyrimidone derivatives
PCT/EP2001/003636 WO2001070725A1 (en) 2000-03-23 2001-03-22 2-[indanylamino]pyrimidone and 2-[tetrahydronaphthalenylamino]pyrimidone derivatives

Publications (1)

Publication Number Publication Date
AU2001262149A1 true AU2001262149A1 (en) 2001-10-03

Family

ID=8173612

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001262149A Abandoned AU2001262149A1 (en) 2000-03-23 2001-03-22 2-(indanylamino)pyrimidone and 2-(tetrahydronaphthalenylamino)pyrimidone derivatives

Country Status (3)

Country Link
EP (1) EP1136486A1 (en)
AU (1) AU2001262149A1 (en)
WO (1) WO2001070725A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1197621C (en) 2000-04-26 2005-04-20 卫材株式会社 Medicinal compositions promoting bowel movement
TWI330183B (en) 2001-10-22 2010-09-11 Eisai R&D Man Co Ltd
TWI301834B (en) 2001-10-22 2008-10-11 Eisai R&D Man Co Ltd Pyrimidone compound and pharmaceutical composition including the same
WO2006117212A2 (en) 2005-05-04 2006-11-09 Develogen Aktiengesellschaft Use of gsk-3 inhibitors for preventing and treating pancreatic autoimmune disorders
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW520362B (en) * 1996-12-05 2003-02-11 Amgen Inc Substituted pyrimidine compounds and pharmaceutical composition comprising same
AR023052A1 (en) * 1998-09-25 2002-09-04 Mitsuharu Yoshimura Milton DERIVATIVES OF PIRIMIDONA

Also Published As

Publication number Publication date
EP1136486A1 (en) 2001-09-26
WO2001070725A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
AU2002221047A1 (en) Quinazolinone derivatives
AU2001262150A1 (en) 2-(nitrogen-heterocyclic)pyrimidone derivatives
AU2002226486A1 (en) Novel c-glycoside derivatives and use thereof
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU5759999A (en) Pyrimidone derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2002226487A1 (en) Novel c-glycoside derivatives and use thereof
AU2002212436A1 (en) Quinazoline derivatives
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001248365A1 (en) 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2002339185A1 (en) Pyridine and pyrimidine derivatives
AU2001292137A1 (en) Quinazoline derivatives
AU2002224018A1 (en) Pyrimidine derivatives and herbicides containing the same
AU2002234010A1 (en) Benzamidine derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU2001242523A1 (en) Aminophenyl pyrimidone derivatives
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001262149A1 (en) 2-(indanylamino)pyrimidone and 2-(tetrahydronaphthalenylamino)pyrimidone derivatives
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU7271600A (en) Quinazolinone and azaquinazolinone derivatives
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives